vs

Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Mayville Engineering Company, Inc. (MEC). Click either name above to swap in a different company.

Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $134.3M, roughly 1.3× Mayville Engineering Company, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 10.7%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -8.8%).

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Mayville Engineering Company, Inc. is a U.S.-headquartered leading manufacturer of metal components, fabricated assemblies, and custom engineered solutions. It serves OEM clients across agriculture, construction, transportation, defense, and power sports markets, offering end-to-end services from prototyping to high-volume production for North America.

ESPR vs MEC — Head-to-Head

Bigger by revenue
ESPR
ESPR
1.3× larger
ESPR
$168.4M
$134.3M
MEC
Growing faster (revenue YoY)
ESPR
ESPR
+133.0% gap
ESPR
143.7%
10.7%
MEC
Faster 2-yr revenue CAGR
ESPR
ESPR
Annualised
ESPR
10.6%
-8.8%
MEC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESPR
ESPR
MEC
MEC
Revenue
$168.4M
$134.3M
Net Profit
$-4.4M
Gross Margin
6.8%
Operating Margin
50.6%
-4.1%
Net Margin
-3.2%
Revenue YoY
143.7%
10.7%
Net Profit YoY
-127.3%
EPS (diluted)
$0.32
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESPR
ESPR
MEC
MEC
Q4 25
$168.4M
$134.3M
Q3 25
$87.3M
$144.3M
Q2 25
$82.4M
$132.3M
Q1 25
$65.0M
$135.6M
Q4 24
$69.1M
$121.3M
Q3 24
$51.6M
$135.4M
Q2 24
$73.8M
$163.6M
Q1 24
$137.7M
$161.3M
Net Profit
ESPR
ESPR
MEC
MEC
Q4 25
$-4.4M
Q3 25
$-31.3M
$-2.7M
Q2 25
$-12.7M
$-1.1M
Q1 25
$-40.5M
$20.0K
Q4 24
$16.0M
Q3 24
$-29.5M
$3.0M
Q2 24
$-61.9M
$3.8M
Q1 24
$61.0M
$3.2M
Gross Margin
ESPR
ESPR
MEC
MEC
Q4 25
6.8%
Q3 25
11.0%
Q2 25
10.3%
Q1 25
11.3%
Q4 24
8.9%
Q3 24
12.6%
Q2 24
13.6%
Q1 24
13.0%
Operating Margin
ESPR
ESPR
MEC
MEC
Q4 25
50.6%
-4.1%
Q3 25
-11.4%
0.0%
Q2 25
8.6%
0.1%
Q1 25
-34.0%
1.2%
Q4 24
-6.4%
19.0%
Q3 24
-31.0%
4.2%
Q2 24
3.5%
5.0%
Q1 24
52.5%
4.7%
Net Margin
ESPR
ESPR
MEC
MEC
Q4 25
-3.2%
Q3 25
-35.9%
-1.9%
Q2 25
-15.4%
-0.8%
Q1 25
-62.2%
0.0%
Q4 24
13.2%
Q3 24
-57.2%
2.2%
Q2 24
-83.9%
2.3%
Q1 24
44.3%
2.0%
EPS (diluted)
ESPR
ESPR
MEC
MEC
Q4 25
$0.32
$-0.22
Q3 25
$-0.16
$-0.13
Q2 25
$-0.06
$-0.05
Q1 25
$-0.21
$0.00
Q4 24
$-0.14
$0.76
Q3 24
$-0.15
$0.14
Q2 24
$-0.33
$0.18
Q1 24
$0.34
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESPR
ESPR
MEC
MEC
Cash + ST InvestmentsLiquidity on hand
$167.9M
$1.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$-302.0M
$240.7M
Total Assets
$465.9M
$563.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESPR
ESPR
MEC
MEC
Q4 25
$167.9M
$1.5M
Q3 25
$92.4M
$1.2M
Q2 25
$86.1M
$206.0K
Q1 25
$114.6M
$183.0K
Q4 24
$144.8M
$206.0K
Q3 24
$144.7M
$178.0K
Q2 24
$189.3M
$314.0K
Q1 24
$226.6M
$314.0K
Stockholders' Equity
ESPR
ESPR
MEC
MEC
Q4 25
$-302.0M
$240.7M
Q3 25
$-451.4M
$244.8M
Q2 25
$-433.5M
$246.8M
Q1 25
$-426.2M
$250.0M
Q4 24
$-388.7M
$251.8M
Q3 24
$-370.2M
$238.4M
Q2 24
$-344.2M
$238.1M
Q1 24
$-294.3M
$234.0M
Total Assets
ESPR
ESPR
MEC
MEC
Q4 25
$465.9M
$563.6M
Q3 25
$364.0M
$585.6M
Q2 25
$347.1M
$433.7M
Q1 25
$324.0M
$447.7M
Q4 24
$343.8M
$445.6M
Q3 24
$314.1M
$466.0M
Q2 24
$352.3M
$488.2M
Q1 24
$373.1M
$499.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESPR
ESPR
MEC
MEC
Operating Cash FlowLast quarter
$45.2M
$13.4M
Free Cash FlowOCF − Capex
$10.2M
FCF MarginFCF / Revenue
7.6%
Capex IntensityCapex / Revenue
0.0%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$26.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESPR
ESPR
MEC
MEC
Q4 25
$45.2M
$13.4M
Q3 25
$-4.3M
$1.9M
Q2 25
$-31.4M
$15.0M
Q1 25
$-22.6M
$8.3M
Q4 24
$-35.0M
$38.0M
Q3 24
$-35.3M
$17.9M
Q2 24
$-7.2M
$23.3M
Q1 24
$53.8M
$10.6M
Free Cash Flow
ESPR
ESPR
MEC
MEC
Q4 25
$10.2M
Q3 25
$-1.1M
Q2 25
$12.5M
Q1 25
$5.4M
Q4 24
$35.6M
Q3 24
$-35.5M
$15.1M
Q2 24
$-7.3M
$19.2M
Q1 24
$53.8M
$7.8M
FCF Margin
ESPR
ESPR
MEC
MEC
Q4 25
7.6%
Q3 25
-0.8%
Q2 25
9.5%
Q1 25
4.0%
Q4 24
29.4%
Q3 24
-68.7%
11.1%
Q2 24
-9.9%
11.7%
Q1 24
39.0%
4.9%
Capex Intensity
ESPR
ESPR
MEC
MEC
Q4 25
0.0%
2.4%
Q3 25
0.0%
2.1%
Q2 25
0.0%
1.8%
Q1 25
0.0%
2.2%
Q4 24
0.0%
1.9%
Q3 24
0.3%
2.1%
Q2 24
0.1%
2.5%
Q1 24
0.1%
1.7%
Cash Conversion
ESPR
ESPR
MEC
MEC
Q4 25
Q3 25
Q2 25
Q1 25
416.65×
Q4 24
2.38×
Q3 24
6.03×
Q2 24
6.15×
Q1 24
0.88×
3.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

MEC
MEC

Fabrication$72.2M54%
Construction And Access$19.2M14%
Tubes$16.2M12%
Other Market$11.9M9%
Agriculture$7.7M6%
Military$6.7M5%
Outdoor Sports$1.7M1%

Related Comparisons